SecBot SecBot
← Back to Analyst Consensus
KPRX Buy

KIORA PHARMACEUTICALS INC

Current Price —
Implied Upside —
Analysts 7

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 0 firms

Next Earnings

Nov 5, 2026 (9 days)

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Sep 2, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Mar 28, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Nov 12, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Aug 22, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Jul 23, 2024HC Wainwright & Co.maintainBuy → Buy$1044%
May 20, 2024HC Wainwright & Co.reiterateBuy → Buy$244%
Mar 27, 2024HC Wainwright & Co.maintainBuy → Buy$244%
Feb 9, 2024HC Wainwright & Co.maintainBuy → Buy$244%
Nov 13, 2023HC Wainwright & Co.reiterateBuy → Buy$3.544%
Nov 6, 2023HC Wainwright & Co.maintainBuy → Buy$3.544%
Aug 24, 2023HC Wainwright & Co.reiterateBuy → Buy$244%
Aug 14, 2023HC Wainwright & Co.maintainBuy → Buy$244%
Aug 9, 2023Maxim GroupmaintainBuy → Buy$241%
May 12, 2023HC Wainwright & Co.maintainBuy → Buy$744%
Mar 24, 2023HC Wainwright & Co.reiterate— → Buy$644%
Feb 9, 2023Maxim GroupupgradeHold → Buy$1241%
Feb 8, 2023HC Wainwright & Co.reiterate— → Buy$1044%
Feb 8, 2023Ladenburg Thalmannreiterate— → Buy$11945%

Price Target Trend

Apr 2, 2026 Oct 26, 2026

EPS Estimates

+1y —
0y —
+1q —
0q —

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access